NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

568 hedge funds and large institutions have $10.7B invested in Neurocrine Biosciences in 2024 Q3 according to their latest regulatory filings, with 68 funds opening new positions, 235 increasing their positions, 199 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
568
Holders Change
-22
Holders Change %
-3.73%
% of All Funds
8.22%
Holding in Top 10
10
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+25%
% of All Funds
0.14%
New
68
Increased
235
Reduced
199
Closed
85
Calls
$79.4M
Puts
$74M
Net Calls
+$5.4M
Net Calls Change
-$66.4M

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$203M
2
DM
2
Deerfield Management
New York
$152M
3
AQR Capital Management
3
AQR Capital Management
Connecticut
$212M
4
State Street
4
State Street
Massachusetts
$593M
5
Los Angeles Capital Management
5
Los Angeles Capital Management
California
$48.5M

Top Sellers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$173M
2
AC
2
Armistice Capital
New York
$20.9M
3
1832 Asset Management
3
1832 Asset Management
Ontario, Canada
$0
4
PCH
4
Polar Capital Holdings
United Kingdom
$2.3M
5
Westfield Capital Management
5
Westfield Capital Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
JFGIW
651
Johnson Financial Group Inc (Wisconsin)
Wisconsin
– -$1.38K -10 Closed
TFM
652
TFC Financial Management
Massachusetts
– -$551 -4 Closed
23 24 25 26
27